Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	709.04	-563.87	69.70
Graham Fair Price	251.12	4.30	1.22
PEG	-99.70	-0.03	9.62
Price/Book	-7.31	1.12	1.21
Price/Cash Flow	64.25	-58.74	-164.33
Prices/Earnings	92.66	-33.31	-454.14
Price/Sales	38.75	6.17	4.45
Price/FCF	64.25	-58.74	-164.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-27.64	0.18	0.26
Operating Margin	1127.07	-0.05	< 0.005
ROA	-1139.75	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-1163.60
ROIC	< 0.005	< 0.005	875.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.16	-42.34
Dividends QOQ	-0.07	0.27	278.53
EBIT QOQ	-0.21	-9.14	-4154.37
EPS QOQ	0.47	-11.58	2352.49
FCF QOQ	0.73	-1.57	116.91
Revenue QOQ	0.14	-0.34	132.61
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	118.64	172.57	45.45
Days Sales Outstanding (DSO)	240.58	329.81	37.09
Inventory Turnover	0.76	0.52	-31.25
Debt/Capitalization	0.45	0.48	5.24
Quick Ratio	1.00	0.93	-7.38
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.02	9.90	-1.22
Cash	2.17	2.37	9.50
Capex	-0.37	-0.43	-16.64
Free Cash Flow	-0.07	-0.19	-156.14
Revenue	2.72	1.79	-34.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.31	1.29	-1.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	24.55	-220.14	796.70
Naive Interpretation	Member

06 - Financial Health · Weak

Rating